Novel, activated RAS mutations alter protein-protein interactions

B K Dalley1, J F Cannon

  • 1Department of Molecular Microbiology and Immunology, University of Missouri, Columbia 65212, USA.

Oncogene
|September 19, 1996
PubMed

Insights

Researchers screened random RAS2 mutants in yeast, identifying 69 mutations. Activated RAS2 proteins showed altered interactions with key regulatory proteins, influencing cellular signaling pathways.

Area of Science:

  • Molecular Biology
  • Yeast Genetics
  • Cell Signaling

Background:

  • RAS proteins are key regulators of cellular signaling pathways.
  • Activating mutations in RAS genes can lead to uncontrolled cell growth.
  • Understanding RAS2 function and regulation is crucial for deciphering cellular processes.

Purpose of the Study:

  • To identify and characterize activating mutations in the RAS2 gene of Saccharomyces cerevisiae.
  • To investigate how these mutations affect the interactions of RAS2 with its regulatory and effector proteins.
  • To elucidate the molecular mechanisms underlying RAS2 activation.

Main Methods:

  • Screening of random RAS2 mutants in yeast for activating traits.
  • Identification and characterization of 69 distinct mutations affecting 44 amino acid residues.
  • In vivo interaction assays of mutant RAS2 proteins with adenylate cyclase, RAF, CDC25, IRA2, and NF1.

Main Results:

  • Nearly all activated RAS2 mutants showed enhanced interaction with adenylate cyclase and RAF.
  • Some mutations reduced RAS2 affinity for guanine nucleotides, increasing nucleotide-free RAS2 fraction and CDC25 affinity.
  • Mutations affecting affinity for GTPase activating proteins were identified both within and outside the switch I/II domain.

Conclusions:

  • RAS2 activation involves complex alterations in protein-protein interactions and nucleotide binding.
  • The study provides insights into how specific amino acid substitutions modulate RAS2 function.
  • Findings contribute to a deeper understanding of RAS signaling and its regulation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...